- 3-Aminobenzoic Acid
- 2016-11-02 21:17
- CAS No.: 99-05-8Content: ≥ 98.5%Appearance: White-like crystalline PowderFormula: C7H7NO7Moisture: ≤ 0.5%Residue on ig
- Benzocaine (USP34/EP7) COS/CEP/GMP certified
- 2016-09-10 10:23
- Benzocaine (USP34/EP7) COS/CEP/GMP certifiedCAS#: 94-09-7Content: 98-102% Appearance: White Crystalline Powder Melting P
- 5,6-Dichloroindole
- 2016-09-10 10:22
- 5,6-DichloroindoleCAS#: *-57-2Appearance: White-like Powder Content: min 97.0%Packing: 25kg fiber drumCoco LiMobile: +86
- 3-(3-Trifluoromethylphenyl)propionic acid
- 2016-09-10 10:10
- Key Intermediates for Cinacalcet hydrocloride: 3-(3-Trifluoromethylphenyl)propionic acidCAS#: 585-50-2Content: min 99% A
- (R)-1-(1-Naphthyl) ethylamine hydrocloride
- 2016-09-10 10:10
- Key Intermediates for Cinacalcet hydrocloride: (R)-1-(1-Naphthyl)ethylamine hydroclorideCAS#: *-04-1Optical isomers chir
- 3-(3-Trifluoromethyl phenyl) propanol
- 2016-09-10 10:10
- Key Intermediates for Cinacalcet hydrocloride: 3-(3-Trifluoromethyl phenyl) propanolCAS#: *-45-2Appearance: Yellow to br
- 4-(2-Aminoethyl)benzene sulfonamide
- 2016-09-10 10:10
- Key Intermediates for Glimepiride: 4-(2-Aminoethyl)benzene sulfonamide CAS#: *-76-5Content: 98-101% Appearance: White or
- 4-Sulfamoylphenylhydrazine.HCl
- 2016-09-10 10:10
- Key Intermediates for Celecoxib: 4-Sulfamoylphenylhydrazine.HClCAS#: *-52-7Content: min 99% Appearance: Off-White crysta
- (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phe
- 2016-09-10 10:10
- Key Intermediates for Rivaroxaban: (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-oneCAS#: *-10-0Cont
- 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine
- 2016-09-10 10:10
- Key Intermediates for Quetiapine: 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepineCAS#: 3159-07-7Content: min 99% Appeara
- ETHYL (R,S)-4-CHLORO-3-HYDROXYBUTANOATE
- 2016-09-10 10:10
- Key Intermediates for OxiracetamETHYL (R,S)-4-CHLORO-3-HYDROXYBUTANOATECAS#: *-69-4Content: min 98% Appearance: Light ye
- (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine
- 2016-09-10 10:10
- Key Intermediates for Moxifloxacin(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridineCAS#: *-40-0Content: min 99% Appearance: